Purdue Pharma cuts ties with PhRMA

Purdue Pharma has voluntarily resigned from the Pharmaceutical Research and Manufacturers of America, the drug industry's top lobbying group, according to STAT.

A member of PhRMA told STAT that Purdue Pharma, which made oxycontin and has come under intense scrutiny for its part in fueling the opioid crisis, cut ties with the lobbying group in October. 

A Purdue Pharma spokesperson told STAT that the decision "does not reflect any substantive disagreement with PhRMA" and it does not have to do with the drugmaker's role in the opioid crisis. 

The split may be because Purdue Pharma can't afford the membership fees, as it filed for bankruptcy in September. The lobbying group has expensive membership fees and also requires members to spend at least $200 million each year on research and development, according to STAT.

Lobbyists were reportedly surprised Purdue Pharma left the group, and several told STAT they were unaware Purdue Pharma had left. 

Read the full article here

More articles on pharmacy:
Humana to buy hospice pharmacy Enclara Healthcare
Kite Pharma ordered to pay Juno Therapeutics $752M in CAR-T drug infringement case
Walgreens is Dow's worst-performing stock of 2019

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars